Motley Rice attorneys are currently reviewing potential Wellbutrin lawsuits involving women who took Wellbutrin®, Wellbutrin SR® or Wellbutrin XL® during early pregnancy and had a baby born with a congenital heart defect such as left outflow heart defects. Wellbutrin, an antidepressant prescription drug manufactured by GlaxoSmithKline and generically called bupropion hydrochloride, has been linked to serious side effects in women who took this drug during early pregnancy.
Contact a Wellbutrin Lawyer
Lawyers at Motley Rice are currently reviewing potential Wellbutrin lawsuits. If you, a family member or friend took Wellbutrin during early pregnancy and had a baby born with a birth defect, you may contact Wellbutrin lawyer Kimberly Barone Baden by email or by calling 1.800.768.4026 to learn more about your legal rights.
Wellbutrin Side Effects
Wellbutrin is an antidepressant drug prescribed to treat major depressive disorder, also called major depression and clinical depression, and seasonal affective disorder, a type of depression involving adverse side effects that occur each year during the same season. First approved by the FDA in 1985, bupropion hydrochloride was available for several years only under the brand name Wellbutrin. In 1996, the FDA approved a sustained-release tablet of this drug called Wellbutrin SR and, in 2003, approved an extended-release tablet known as Wellbutrin XL.
Wellbutrin carries a Pregnancy Category C classification, meaning that animal reproduction studies have shown an adverse effect on the fetus but that no adequate or well-controlled studies in humans have been performed.
Wellbutrin has been linked to congenital heart defects. Congenital heart defects affect approximately 40,000 babies each year, and one of the primary known causes of such birth defects is the ingestion of teratogenic drugs during pregnancy. A teratogen is a drug or other substance capable of interfering with the development of a fetus that can ultimately result in serious birth defects.
Wellbutrin Birth Defects
A 2010 case-control study published in the American Journal of Obstetrics and Gynecology suggests that women who take Wellbutrin during early pregnancy may run a greater risk for having a baby born with a heart birth defect. This study identifies a positive association between early pregnancy Wellbutrin use and left outflow tract heart birth defects. Researchers caution that the findings of this study are not conclusive and that further research is needed to confirm the findings. Women taking Wellbutrin who are planning to become pregnant should speak with their doctors about the potential side effects and alternative options.